Phenytoin Sodium: Difference between revisions
No edit summary |
No edit summary |
||
| Line 32: | Line 32: | ||
|P1S1S3 | |P1S1S3 | ||
|} | |} | ||
==Mechanism of Action== | |||
Anticonvulsant medication. It is a sodium channel blocker. It binds to sodium channels and suppresses repetitive neuronal firing. | |||
==Dosage== | |||
Doses may be expressed in terms of phenytoin or phenytoin sodium; phenytoin 92 mg is equivalent to about 100 mg phenytoin sodium. | |||
As phenytoin has a narrow therapeutic index, need to monitor plasma-phenytoin concentration. | |||
Anticonvulsant effect: 10-20 micrograms/mL (40 to 80 micromoles/litre) | |||
Antiarrhythmic effect: 10-20 micrograms/mL (40 to 80 micromoles/litre) | |||
''By mouth'', initially 3-4 mg/kg daily or 150 – 300 mg daily (as a single dose or in 2 divided doses) increased gradually as necessary to 600 mg daily. The suggested minimum interval between increments has ranged from about 7 to 10 days. A usual maintenance dose is 200 – 500 mg daily. | |||
For doses in children. | |||
Revision as of 03:53, 5 October 2020
Introduction
Phenytoin is an anticonvulsant medication used primarily in the treatment of:
- Tonic-clonic seizures; focal seizures. A period of 5-10 days may be required to achieve anticonvulsant effects.
- Treatment of seizures during or following neurosurgery or severe head injury;
- Status epilepticus;
- Trigeminal neuralgia if carbamazepine inappropriate;
- Abnormal heart rhythm such as ventricular tachycardia and atrial tachycardia.
Pronunciation
Phenytoin sodium 100mg
Phenytoin sodium 30mg
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Phenytoin Sodium Cap 30mg | PHEN31 | P1S1S3 |
| Phenytoin Sodium Extended | ||
| Release Cap 100mg | PHEN86 | P1S1S3 |
Mechanism of Action
Anticonvulsant medication. It is a sodium channel blocker. It binds to sodium channels and suppresses repetitive neuronal firing.
Dosage
Doses may be expressed in terms of phenytoin or phenytoin sodium; phenytoin 92 mg is equivalent to about 100 mg phenytoin sodium.
As phenytoin has a narrow therapeutic index, need to monitor plasma-phenytoin concentration.
Anticonvulsant effect: 10-20 micrograms/mL (40 to 80 micromoles/litre)
Antiarrhythmic effect: 10-20 micrograms/mL (40 to 80 micromoles/litre)
By mouth, initially 3-4 mg/kg daily or 150 – 300 mg daily (as a single dose or in 2 divided doses) increased gradually as necessary to 600 mg daily. The suggested minimum interval between increments has ranged from about 7 to 10 days. A usual maintenance dose is 200 – 500 mg daily.
For doses in children.
